Bavarian Nordic AS operates in the Biological products exc. diagnostic sector.
In addition to historical fundamental analyses, the complete report available to purchase compares Bavarian Nordic AS with three other
pharmaceutical manufacturers in Europe:
sales of 26.74 million Euro [US$29.62 million]
of which 95%
was Product Sales),
Horizon Discovery Group PLC
of the United Kingdom
(£58.73 million [US$77.08 million]
of which 79%
was Products), and
Bonesupport Holding AB
based in Sweden
(96.62 million Swedish Kronor [US$10.18 million]
of which 53%
was CERAMENT antibiotics).
Bavarian Nordic AS reported sales of 500.62 million Danish Kroner (US$74.23 million)
December of 2018.
decrease of 63.5%
versus 2017, when the company's sales were 1.37 billion Danish Kroner.